Search
Chairs and Members
Chair
Edward Laane, Tartu University, Estonia (2022–2024)
Vice-Chair
Esther Natalie Oliva, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Italy (2022–2024)
Sam Salek, University of Hertfordshire, United Kingdom (2022–2024)
Steering Committee
Tatiana Ionova, St.
Burnout survey
The burnout survey closed on October 25, 2024. Burnout in hematologyBurnout is, in broad terms, a state of physical, mental, and emotional exhaustion.
Read moreJoint EHA and national society membership
Enjoy the best of both worlds—and save money—by combining an EHA membership with membership of your national hematology society. This special type of membership package is the result of our constructive collaborations with a range of national hematology societies.
Read moreEHA-SIE joint membership
Save money and time money by becoming a joint member of EHA and the Società Italiana di Ematologia. We've joined forces with the Società Italiana di Ematologia (SIE) to offer a special joint membership deal.
Read moreEHA-SPSHTM joint membership
Save money and time by becoming a joint member of EHA and the Scientific and Practical Society of Hematologists and Transfusiologists from the Republic of Moldova.
Read moreSustainability
Actions we're taking to reduce the environmental impact of our flagship event: the EHA Congress.
Read moreChairs and Members
Chair
Claire Harrison, Guy’s and St Thomas’ NHS Foundation Trust, Guy’s Hospital, London (United Kingdom)
Co-chair
Jean-Jacques Kiladjian, Hôpital Saint-Louis and Paris Diderot University, Paris (France)
SWG Steering Committee members
Alessandro Vannucchi, University of Florence (Italy)
Antonio Almeida, Hospital da Luz (Portugal)
Carlos Besses, Barcelona Biomedical Research…
Selected EMA news
November 2024New medicines recommended for approval
Eltrombopag Viatris (eltrombopag) – generic
Treatment of primary immune thrombocytopenia and thrombocytopenia associated with chronic hepatitis C (disease in which patients have low levels of blood platelets)
Alhemo (concizumab)
Prevention of bleeding in patients with hemophilia A…
I4MDS consortium: advancing MDS treatment and understanding
The role of the immune system in the pathophysiology of Myelodysplastic Neoplasms (MDS) is firmly established. However, routine immune monitoring for these patients is still not a common practice.
Read more